Research demonstrates a novel inhibitor induces linear polyubiquitin accumulation in living cells, suggesting enhanced profiling of interactors.
Dynamically profiling of interactors of polyubiquitin (polyUb) chain topologies facilitates deciphering their functional specificity. Current strategies employing antibodies, synthetic antigen-binding fragments (sABs), or ″Affimers″ often lack temporal resolution and face challenges in detecting interactors of low-abundance polyUb chains, such as linear Ub (<0.2% of total Ub chains). Here, we structure-guided designed a photoactivatable OTULIN-specific inhibitor, linear-diUbp-Glu16(4-methoxy-7-nitroindoline, MNI)-dehydroalanine (Dha), which enables transient inhibition of this exclusively linear-specific deubiquitinase in living cells, thereby inducing rapid accumulation of linear Ub chains. Based on this tool, we developed a new strategy of synergizing the linear-diUbp-Glu16(MNI)-Dha with a biotinylated linear-antigen-binding fragment (Fab), which facilitated time-resolved profiling of linear polyubiquitination interactors in both TNF-α stimulated HeLa cells and macrophage colony-stimulating factor (M-CSF)-induced bone-marrow-derived macrophages. Our work also provides new opportunities for analyzing interactors of other low-abundance Ub chains, especially in hard-to-transfect cells, and highlights the effectiveness of chemical protein synthesis in developing advanced protein tools for biological discovery.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: